Blog Posts - 23 April 2019
With the adoption of solutions like Veradigm’s Price Transparency accelerating rapidly, now is an ideal time for patients to make a more conscious effort to take charge of their healthcare.
Blog Posts - 23 April 2019
Veradigm™ worked with Xtelligent Healthcare Media to produce an article "How to be more effective in HEDIS reporting."
Blog Posts - 15 April 2019
A clinician's perspective on how to address medication affordability through price transparency.
Blog Posts - 08 April 2019
Addressing medication affordability through the Veradigm TruePriceRx™ prescription price transparency solution is an example of how Veradigm is working to make this transformation a reality.
Thought Leadership - 01 April 2019
A retrospective data analysis using de-identified patient data may provide insights regarding HFpEF (Heart Failure with Preserved Ejection Fraction) and improve the quality of life.
Blog Posts - 22 March 2019
Quality measure implications of 30-day medication reconciliation, a Pharmacist perspective for Health Plans outlining current challenges and a potential solution.
Press Releases - 19 March 2019
Pulse8, part of Veradigm™, an Allscripts business unit, the first – and ONLY one with a patent pending – healthcare analytics and technology company delivering complete visibility into the efficacy of Risk Adjustment, Quality Management, and Pharmacy Benefit Management programs, is excited to become the latest collaborating partner within the Health Plan Alliance Group Purchasing Organization (GPO).
Press Releases - 18 March 2019
Pulse8, part of Veradigm™, an Allscripts business unit, the first – and ONLY one with a patent pending – healthcare analytics and technology company delivering complete visibility into the efficacy of Risk Adjustment, Quality Management, and Pharmacy Benefit Management programs, proudly debuted several significant enhancements to its illumin8 Solution Suite this quarter.
Press Releases - 13 March 2019
Veradigm™, an Allscripts business unit, announced today that it has strengthened its strategic relationship with Pulse8, a leader in healthcare analytics and technology company.
Blog Posts - 07 March 2019
Veradigm™ partners with Surescripts for a conversation on price transparency at HIMSS19. Watch video highlights from panel discussion.
Thought Leadership - 04 March 2019
Read how Veradigm™ leverages Systolic Heart Failure Real-World Evidence in a Case Study using Electronic Health Records.
Blog Posts - 21 February 2019
Last week’s HIMSS19 conference (Healthcare Information Management Systems Society conference), the largest Healthcare IT conference of the year, provided a wealth of opportunities for attendees to gather information on prominent topics in global healthcare.
Blog Posts - 19 February 2019
On February 11, 2018, the Centers for Medicare and Medicaid Services (CMS) released the much-anticipated Interoperability and Patient Access Proposed Rule after delays that resulted from the government shut-down.
Press Releases - 13 February 2019
Today, Veradigm™, an Allscripts (NASDAQ:MDRX) business providing integrated health care data systems and services, and NextGen Healthcare Inc. (NASDAQ:NXGN), a leading provider of ambulatory-focused healthcare technology solutions, entered into a long-term agreement.
Blog Posts - 11 February 2019
Through an agreement announced at the annual HIMSS conference, MIB’s 400 life insurance member companies will be able to access medical records electronically via Veradigm’s eChart Courier™ service.
Blog Posts - 06 February 2019
Anyone who consumes such analgesics or other drugs for symptomatic treatment of headache and happens to be one of the 45 million Americans with migraine or chronic tension-type headache may be at risk of medication overuse headache.
Press Releases - 05 February 2019
Veradigm is leveraging its capability to communicate directly with a broad network of ambulatory healthcare professionals (HCPs) in order to increase public awareness and access to the Cancer Experience Registry.
Blog Posts - 05 February 2019
The DaVinci project is working to improve clinical data exchange between health plans and providers.
Blog Posts - 29 January 2019
On December 7, 2018, the FDA released the Framework for FDA’s Real World Evidence program, and the regulatory team at Veradigm has provided a brief overview below, including information from the report related to definitions, usability, and stakeholder involvement.
Blog Posts - 24 January 2019
Integrating clinical experience into Health IT is becoming more prominent. Here’s why a PharmD chose to leave clinical full time to Veradigm.
Blog Posts - 23 January 2019
The CMS Hospital Price Transparency Rule provides patients with visibility to cost information, but also has the potential to cause confusion. Health Plans should consider implications to call centers and ensure their ability to help members understand the information they will be receiving.
Blog Posts - 17 January 2019
Navigating an EHR can be challenging. Innovative solutions from Veradigm can help enhance EHR success today.
Blog Posts - 16 January 2019
On November 23, 2018, the Centers for Medicare and Medicaid Services (CMS) published the 2019 Medicare Physician Fee Schedule Final Rule which updates payment policies, payment rates, and other provisions for services furnished under the Medicare Physician Fee Schedule (PFS) on or after January 1, 2019.
Blog Posts - 11 January 2019
Between pending federal legislation on price transparency and the rising tide of patient self-empowerment, there has never been more focus on closing the gap between patients’ prescription out-of-pocket (OOP) costs and what they can afford to pay.
Thought Leadership - 10 January 2019
The advances in medical science over recent decades have been startling, yet the process of demonstrating the safety, efficacy, and patient value of new therapies and clinical practices remains inefficient.
Press Releases - 07 January 2019
Today, Allscripts (NASDAQ:MDRX), a global leader in health care information technology, announced a collaboration with Microsoft focused on implementing an innovative, integrated model for clinical research, aiming to enhance clinical research design, conduct studies more efficiently and improve the research provider and participant experience.
Blog Posts - 04 January 2019
It has been estimated that a third or more of what the U.S. spends annually on healthcare could be eliminated without impacting the quality of care.
Press Releases - 10 December 2018
Surescripts Real-Time Prescription Benefits saves patients up to $8,082 on a single prescription, reduces prior authorizations and saves thousands of hours of wait time.
Blog Posts - 28 November 2018
Over the last several years, there has been a dramatic increase in the demand for more specialized EHR platforms, which has in turn given rise to many new, smaller, highly innovative healthcare IT companies.
Blog Posts - 20 November 2018
There is significant opportunity to reduce waste in the healthcare ecosystem by automating manual processes with savings opportunities for both payers and HCPs. Automating manual processes also improve payer-provider relationships and enhances member satisfaction.
Blog Posts - 19 November 2018
Veradigm supports BioPharma companies with a broad range of dynamic media solutions to effectively and appropriately communicate key messages to healthcare providers within their existing daily workflow.
Press Releases - 14 November 2018
Chicago, IL, Nov 14, 2018 - Veradigm is a leader in providing data-driven health insights and analytic solutions designed to increase efficiency and help manage the cost of healthcare.
Blog Posts - 15 November 2018
The 2019 Physician Fee Schedule Final Rule was released on November 1, 2018 by the Centers for Medicare and Medicaid Services (CMS).
Thought Leadership - 14 November 2018
Migraine, an underdiagnosed and undertreated primary headache disorder characterized by recurrent, painful attacks, affects an estimated 36 million Americans.
Blog Posts - 14 November 2018
Veradigm is working to make it easier for doctors to help their patients appropriately reduce the cost and wait time for their medication.